Finance

Lists
AVAH:NASDAQ
Aveanna Healthcare Holdings Inc
$12.97
-1.44%
(-0.19) 1D
$11.78
-9.18% (-1.19)
After hours
Closed: Aug 20, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVAH...
Open
$13.04
High
$13.40
Low
$12.90
Mkt. cap
2.83B
Avg. vol.
2.60M
Volume
3.28M
P/E ratio
10.57
52-wk high
$13.40
52-wk low
$5.93
EPS
$1.23
Beta
1.90
Shares outstanding
218.22M
No. of employees
20K
Open
$13.04
High
$13.40
Low
$12.90
Mkt. cap
2.83B
Avg. vol.
2.60M
Volume
3.28M
P/E ratio
10.57
52-wk high
$13.40
52-wk low
$5.93
EPS
$1.23
Beta
1.90
Shares outstanding
218.22M
No. of employees
20K
News stories
From web sources and news partners
About Aveanna Healthcare Holdings Inc
CEO-
Employees19.5K
Founded2016
HeadquartersAtlanta, Georgia, United States
SectorHealth care provider
Websiteaveanna.com
Analyst ratings
Based on 7 analysts giving stock ratings to AVAH in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AVAH in the last 3 months.
Highest
Current $12.97
$16.00 (+23.36%)
Average
$12.50 (-3.62%)
Lowest
$9.50 (-26.75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
UBS
Hold
Reiterated
$13.00
+0.2%
08/14/2026
Unknown Analyst
Deutsche Bank
Buy
Maintained
$16.00
+23.4%
08/14/2026
David S Macdonald
Truist Financial
Hold
Maintained
-
-
08/14/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$14.00
+7.9%
08/14/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$9.50
-26.8%
08/14/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/13/2026
Srikripa Devarakonda
Truist Financial
Hold
Reiterated
-
-
06/08/2026
Ben Hendrix
RBC Capital
Buy
Upgraded
$10.00
-22.9%
06/03/2026
Unknown Analyst
Stephens
Buy
Upgraded
$11.00
-15.2%
05/15/2026
Raj Kumar CFA
Stephens
Buy
Upgraded
$11.00
-15.2%
05/15/2026
Benjamin Rossi
J.P. Morgan
Hold
Maintained
$8.00
-38.3%
03/27/2026
John Ransom
Raymond James
Buy
Maintained
$13.00
+0.2%
03/20/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$10.00
-22.9%
03/20/2026
Last report
Aug 13, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.22 / $0.17
+31.59%beat
Revenue / Est. (USD)
670.48M / 638.63M
+4.99%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
621.94M
662.48M
647.92M
670.48M
Cost of goods sold
419.12M
455.38M
442.49M
451.96M
Cost of revenue
419.12M
455.38M
442.49M
451.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
131.40M
129.97M
129.95M
131.16M
Operating expense
134.42M
131.91M
132.99M
134.16M
Total operating expenses
553.53M
587.29M
575.48M
586.11M
Operating income
68.41M
75.19M
72.44M
84.37M
Other non operating income
2.70M
3.68M
4.99M
5.02M
EBT including unusual items
13.42M
39.24M
44.98M
56.47M
EBT excluding unusual items
34.10M
45.26M
48.08M
60.86M
Income tax expense
-647.00K
-139.51M
3.32M
16.18M
Effective tax rate
-4.82%
-355.48%
7.39%
28.65%
Other operating expenses
418.00K
-788.00K
-
144.00K
Net income
14.06M
178.75M
41.65M
40.29M
Net profit margin
2.26%
26.98%
6.43%
6.01%
Earnings per share
0.15
0.17
0.18
0.22
Interest and investment income
826.00K
1.74M
1.66M
1.26M
Interest expense
-37.83M
-35.35M
-31.00M
-29.79M
Net interest expenses
-37.00M
-33.61M
-29.34M
-28.53M
Depreciation and amortization charges
2.60M
2.73M
3.04M
2.85M
EBITDA
71.01M
77.52M
75.48M
87.22M
Gain or loss from assets sale
402.00K
1.14M
-24.00K
144.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps